FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Auro Impex & Chemicals IPO and Remus Pharmaceuticals IPO.
Auro Impex & Chemicals IPO is a SME Book Built Issue IPO proposed to list at NSE SME while Remus Pharmaceuticals IPO is a SME Book Built Issue proposed to list at NSE SME.
Auro Impex & Chemicals IPO | Remus Pharmaceuticals IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Affinity Global Capital Market Private Limited | Beeline Capital Advisors Pvt Ltd |
Registrar | Cameo Corporate Services Limited | Link Intime India Private Ltd |
Market Maker | Rikhav Securities Limited | Sunflower Broking Private Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Auro Impex & Chemicals IPO is up to ₹27.07 Cr whereas the issue size of the Remus Pharmaceuticals IPO is up to ₹47.69 Cr. The final issue price of Auro Impex & Chemicals IPO is ₹78.00 per share and of Remus Pharmaceuticals IPO is ₹1,229.00 per share.
Auro Impex & Chemicals IPO | Remus Pharmaceuticals IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹74.00 per share | ₹1,150.00 per share |
Issue Price (Upper) | ₹78.00 per share | ₹1,229.00 per share |
Issue Price (Final) | ₹78.00 per share | ₹1,229.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1600 shares | 100 shares |
Fresh Issue Size | 29,20,000 shares | 3,88,000 shares |
Fresh Issue Size (Amount) | up to ₹22.78 Cr | up to ₹47.69 Cr |
OFS Issue Size | 5,50,400 shares | |
OFS Issue Size (Amount) | up to ₹4.29 Cr | |
Issue Size Total | 34,70,400 shares | 3,88,000 shares |
Issue Size Total (Amount) | up to ₹27.07 Cr | up to ₹47.69 Cr |
Auro Impex & Chemicals IPO opens on May 11, 2023, while Remus Pharmaceuticals IPO opens on May 17, 2023. The closing date of Auro Impex & Chemicals IPO and Remus Pharmaceuticals IPO is May 15, 2023, and May 19, 2023, respectively.
Auro Impex & Chemicals IPO | Remus Pharmaceuticals IPO | |
---|---|---|
Anchor Bid Date | May 16, 2023 | |
Issue Open | May 11, 2023 | May 17, 2023 |
Issue Close | May 15, 2023 | May 19, 2023 |
Basis Of Allotment (Tentative) | May 18, 2023 | May 24, 2023 |
Initiation of Refunds (Tentative) | May 19, 2023 | May 25, 2023 |
Credit of Share (Tentative) | May 22, 2023 | May 26, 2023 |
Listing date (Tentative) | May 23, 2023 | May 29, 2023 |
Anchor Lockin End date 1 | Jun 17, 2023 | Jun 23, 2023 |
Anchor Lockin End date 2 | Aug 16, 2023 | Aug 22, 2023 |
Auro Impex & Chemicals IPO P/E ratio is 12.07, as compared to Remus Pharmaceuticals IPO P/E ratio of 21.09.
Auro Impex & Chemicals IPO | Remus Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.99% | 92.82% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 68.37% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 12.07 | 21.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹95.17 Cr. | ₹181.03 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 71.44%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 69.99%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 2.77 | 0.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹6.00 | ₹33.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 19.92%% | 52.64%% |
In the Auro Impex & Chemicals IPO retail investors (RII) are offered 19,44,118 shares while in Remus Pharmaceuticals IPO retail investors are offered 19,44,118 shares. Qualified institutional buyers (QIB) are offered 3,47,040 shares in Auro Impex & Chemicals IPO and 1,38,750 shares in Remus Pharmaceuticals IPO.
Auro Impex & Chemicals IPO | Remus Pharmaceuticals IPO | |
---|---|---|
Anchor Investor Reserveration | 1,10,500 shares | |
Market Maker Reserveration | 1,74,400 shares | 19,500 shares |
QIB | 3,47,040 shares | 1,38,750 shares |
NII | 11,79,242 shares | 41,625 shares |
RII | 19,44,118 shares | 97,125 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 34,70,400 shares | 2,77,500 shares |
Auro Impex & Chemicals IPO subscribed 66.94x in total, whereas Remus Pharmaceuticals IPO subscribed 57.21x.
Auro Impex & Chemicals IPO | Remus Pharmaceuticals IPO | |
---|---|---|
QIB (times) | 31.67x | 10.75x |
NII (times) | 104.05x | 229.31x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 50.72x | 49.81x |
Employee (times) | ||
Other (times) | ||
Total (times) | 66.94x | 57.21x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|